Incyte Corporation Profile Avatar - Palmy Investing

Incyte Corporation

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and p…

Biotechnology
US, Wilmington [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2024 1 $6,000,000 LD-2 : 04/22/24
2024 1 $6,000,000 LD-2 : 04/12/24
2023 4 $6,000,000 LD-2 : 01/22/24
2023 4 $6,000,000 LD-2 : 01/22/24
2023 4 $6,000,000 LD-2 : 01/17/24

Get PRO Today.

Get insights for 7 more lobbying disclosures of Incyte Corporation

End of INCY's Analysis
CIK: 879169 CUSIP: 45337C102 ISIN: US45337C1027 LEI: - UEI: -
Secondary Listings
INCY has no secondary listings inside our databases.